by Batista C, Shoham S, Ergonul O, Hotez P, Elena Bottazzi ME, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow D, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Wilder-Smith A, Sow SO, Yadav P, Strub-Wourgaft N. EClinicalMedicine 2021; 36:100911. doi: 10.1016/j.eclinm.2021.100911
Summary: There is an urgent need to develop efficacious COVID-19 therapeutics to prevent severity and mortality, and to forestall the collapse of overburdened health systems in resource-limited settings. Ending the pandemic is a matter of global health security requiring political leadership to ensure equal access to all tools once they are available. Promising treatment options, meeting the WHO Target Product Profiles for different patient categories, are advancing out of the pipeline. If approved, strong coordination and funding will be required to ensure quick uptake and rollout. Country adoption, community engagement, manufacturing capacity and global coordination will ensure no one is left behind, regardless of where they live.
